Document Detail

Caloric restriction: is mammalian life extension linked to p53?
Jump to Full Text
MedLine Citation:
PMID:  22983298     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Caloric restriction, that is limiting food intake, is recognized in mammals as the best characterized and most reproducible strategy for extending lifespan, retarding physiological aging and delaying the onset of age-associated diseases. The aim of this mini review is to argue that p53 is the connection in the abilities of both the Sirt-1 pathway and the TOR pathway to impact on longevity of cells and organisms. This novel, lifespan regulating function of p53 may be evolutionarily more ancient than its relatively recent role in apoptosis and tumour suppression, and is likely to provide many new insights into lifespan modulation.
Authors:
Paola Tucci
Related Documents :
11356998 - Determination of phylloquinone and menaquinones in food. effect of food matrix on circu...
16512258 - Water-soluble vitamins.
18465178 - Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? part a...
2192628 - The bioavailability of vitamin b6. recent findings.
10227048 - Usual dietary consumption of soy foods and its correlation with the excretion rate of i...
17389908 - Chimpanzees differentially produce novel vocalizations to capture the attention of a hu...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Aging     Volume:  4     ISSN:  1945-4589     ISO Abbreviation:  Aging (Albany NY)     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-09-17     Completed Date:  2013-02-07     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  101508617     Medline TA:  Aging (Albany NY)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  525-34     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aging / metabolism*
Animals
Caloric Restriction*
Cell Cycle / physiology
Cell Death / physiology
Humans
Insulin-Like Growth Factor I / metabolism
Longevity / physiology*
Mammals / metabolism*
Metabolic Networks and Pathways / physiology
Sirtuin 1 / metabolism*
TOR Serine-Threonine Kinases / metabolism*
Tumor Suppressor Protein p53 / genetics,  metabolism*
Grant Support
ID/Acronym/Agency:
MC_U132670600//Medical Research Council; //Medical Research Council
Chemical
Reg. No./Substance:
0/Tumor Suppressor Protein p53; 67763-96-6/Insulin-Like Growth Factor I; EC 2.7.1.1/TOR Serine-Threonine Kinases; EC 3.5.1.-/Sirtuin 1
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Aging (Albany NY)
Journal ID (iso-abbrev): Aging (Albany NY)
Journal ID (publisher-id): ImpactJ
ISSN: 1945-4589
Publisher: Impact Journals LLC
Article Information
Download PDF
Copyright: © 2012 Tucci
open-access:
Received Day: 6 Month: 8 Year: 2012
Accepted Day: 21 Month: 8 Year: 2012
collection publication date: Month: 8 Year: 2012
Electronic publication date: Day: 22 Month: 8 Year: 2012
Volume: 4 Issue: 8
First Page: 525 Last Page: 534
ID: 3461340
PubMed Id: 22983298

Caloric restriction: is mammalian life extension linked to p53?
Paola Tucci12
1 Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK
2 Department of Pharmaco-Biology, University of Calabria, 87036 Rende (CS), Italy
Correspondence: Correspondence to:Paola Tucci, PhD; paola.tucci@unical.it

INTRODUCTION

Caloric restriction (CR), that is limiting food intake, is recognized in mammals as the best characterized and most reproducible strategy for extending lifespan, retarding physiological aging and delaying the onset of age-associated diseases [1]. Restricted calorie intake modifies the rate of aging and cellular pathology, reduces the age-associated accumulation of oxidatively damaged proteins, lipids and DNA and also prevents many of the changes in gene expression and transcriptional activity that normally occur with ageing [1]. Although several theories have been advanced over the years to explain the anti-ageing effects of CR, one favoured hypothesis is that CR acts by decreasing oxidative stress [2]. Biologically, different animal species are characterised by markedly different lifespan. For example, mice have relatively short (around 2-year) mean longevity, whereas humans live to a mean of 70-80 years. Animals with higher metabolic rates often have shorter life spans. The higher the metabolic rate of an organism, the greater the production of reactive oxygen species (ROS) and hence the shorter the life span; however, in some species the strict correlation between metabolic rate and life span is not maintained. Birds and primates, for example, tend to live longer than would be predicted by their metabolic rates. This is because, at a given metabolic rate, mitochondria from these species tend to produce fewer ROS. Thus the accumulation of molecular damage and the resulting increase of oxidative stress caused by ROS was thought to contribute to aging rather than metabolic rate itself and provided the strongest correlation with overall longevity [3]. More recently, however, became evident that the ROS model cannot be the only driving-force of aging. No animal lives long enough to experience the consequences of damage by ROS, since other factors terminate its life first [4]. Further, the overexpression of major antioxidant enzymes, which decrease free radicals, does not extend the lifespan of mice [5], and superoxide dismutases, the major reactive oxygen species regulating autophagy [6], protect against oxidative stress but have little or no effect on life span in C. Elegans [7].

Thus despite impressive progress in identifying the key components of the CR pathway, many proximal effectors of CR induced longevity remain unknown to date. This can be related to the fact that CR causes a myriad of transcriptional and physiological changes that are related to its positive effects on lifespan [8-12]. Are these benefits due to passive effects of lowered caloric intake or is it the result of a highly evolved and regulated process?

The aim of this short review is to argue that CR is indeed a regulated process and that its main regulator pathways, mTOR and Sirt-1, are connected to the p53 pathway.

The mTOR/Sirt-1 pathway

The CR-driven reduction of metabolic rate involves downregulation of the nutrient sensor mammalian target of rapamycin (mTOR), the evolutionarily conserved serine/threonine protein kinase that is strongly involved in most cellular functions and implicated in stimulating cell growth [13-21]. The IGF-1–AKT–TOR network is an evolutionarily conserved pathway that transmits survival signals in cells in response to growth factor stimulation. mTOR is able to regulate both apoptosis and autophagy, and therefore affects the fate of cells. Indeed, apoptosis is clearly implicated in cancer [22-55] as well as in neurodegeneration [56-63]. The binding of a growth factor (IGF-1) to its tyrosine kinase receptor (IGF-1R) results in the recruitment and activation of PI3 kinase to the plasma membrane receptor, which in turn phosphorylates the inositides, increasing the local concentration of PIP3 and PIP2 at the plasma membrane. This increase in lipid second messengers recruits and activates the PDK and AKT protein kinases at the plasma membrane where AKT is then fully activated by phosphorylation of ser-473 and thr-308 [64-71]. AKT has several substrates that are antiapoptotic such as FOXO, BAD [72-73] and MDM2 [74]. In addition the activated AKT protein moves to the cell nucleus where it phosphorylates the forkhead transcription factors. These events result in a program leading to antiapoptotic signalling, preparation for entry into the cell cycle and cell growth, and communication with the TOR kinase pathway, which senses nutrient levels (glucose and amino acids) in the environment. This is accomplished by AKT-1 phosphorylation and inactivation of TSC2 [75-78], which forms a TSC1–TSC2 protein complex that is a GAP for the RHEB G-protein. RHEB, in turn, activates the TOR kinase [79-81]. Thus, an active AKT-1 activates the TOR kinase, both of which are positive signals for cell growth (an increase in cell mass) and division. Furthermore, CR, which reduces the levels of insulin and IGF-1 in serum, has been shown to extend life span and delay the onset of age-associated pathologies through inhibition of TOR [82-85].

The absence of glucose in the cell also increases the levels of AMP, a coactivator of AMPK. Active AMPK positively regulates the activity of the TSC1–TSC2 complex by phosphorylating the TSC2 protein (resulting in the opposite activity to the AKT-1 phosphorylation of TSC2), which then turns off the RHEB G-protein and reduces TOR activity [86].

The TOR kinase regulates two processes that can account for the observed effect of dietary restriction on longevity: translation of selected mRNAs in the cell and autophagy. The first is the rate of protein synthesis, which is modulated by the effect of TOR on the ribosomal protein S6 kinase (S6K) and on the translation initiation factor 4E-binding protein (4E-BP) [87]. It is therefore possible that inhibition of TOR just leads to reduction in the rate of protein synthesis and this is the mechanism of its lifespan prolonging activity. Inhibition of translation may shift cell metabolism to a physiological state that favours maintenance and repair and this may lead to extension of lifespan. Regulation of autophagy is another process by which TOR may affect cell longevity [88]. Accumulating evidence demonstrates that longevity pathways interact with the autophagic process to regulate diverse cellular functions including growth, differentiation, response to nutrient deprivation and oxidative stress, cell death, as well as macromolecule and organelle turnover. This entails the formation of double-membrane vesicles in the cell cytoplasm that engulf cytoplasmic components, including defective mitochondria, and move them to the lysosomal compartment where they are degraded. Autophagy can be induced by stress and also by caloric restriction. The mechanisms by which enhanced autophagy can improve organismal health and longevity are largely elusive. As one possibility, increased autophagy might improve cellular resistance to stress by augmenting the metabolic buffering capacity of cells. Alternatively, autophagy might enhance organellar turnover and mediate a “cleaning effect”, thereby preventing the accumulation of damaged/old organelles [89-105]. But only physiological levels of autophagy can promote survival under stressful conditions. Reduced autophagy may be an oncogenic event and contribute to tumour progression, while enhanced autophagy is activated in tumour cells in which the availability of oxygen and nutrients is poor and represents an adaptive survival mechanism to overcome drug-induced cellular stress and cytotoxicity [106-116]. Thus autophagy is negatively regulated by mTOR, whose activity can be inhibited by rapamycin and caloric restriction [117-124]. Thus, it has been shown that CR slows down aging through inhibition of TOR. On the other hand, it has also been demonstrated that CR activates NAD(+)-dependent deacetylases, called sirtuins, known to be involved in aging and age-related diseases, thus extending lifespan [125-127] (Figure 1). The Sirt-2 gene was shown to regulate life span in yeast; increased dosage extended life span, and loss of function shortened it [128]. A similar relationship exists between the Sirt-2 gene in C. elegans and life span [129]. Because of the enormous evolutionary divergence between yeast and C. elegans, it is likely that Sirt-2-related genes determine the life span in a broad spectrum of organisms, including mammals. Caloric restriction/nutrient deprivation stimulates autophagy through the activation of the mammalian Sirt-1 gene [130-135]. Indeed, Sirt-1 functions as a metabolic sensor that detects the increase in NAD+ concentrations resulting from enhanced NADH oxidation. Once activated, Sirt-1, which is an NAD-dependent HDAC, can deacetylate essential autophagic modulators and may affect cellular pathways involved in glucose homeostasis.

But which pathway is indispensable for prolonged lifespan by CR, inhibiting TOR or activating sirtuins? Evidence has emerged that sirtuins and mTOR are involved in the same longevity pathway [136]. Importantly, resveratrol, an activator of sirtuins, antagonizes the mTOR/S6K pathway [137]. Therefore, the two notions that CR prolongs lifespan either by activating sirtuins or by deactivating TOR are, in fact, complementary: CR deactivates the mTOR pathway in part by activating Sirt-1.

The connection with p53

The p53 protein and its encoding gene were first identified in 1979 because of its association with cancer [138-141] and its function as a tumour suppressor gene [142-168]. In response to various stress signals, p53 selectively regulates a set of its target genes and initiates various stress responses, including cell cycle arrest, apoptosis, and/or senescence, to exert its function in DNA damage and tumour suppression. In addition, p53 may play a dual role in autophagy regulation. On the one hand, nuclear p53 can induce autophagy promoting the transcription of proapoptotic and cell cycle-arresting genes. In contrast, cytoplasmic p53 degradation exerts an autophagy-inhibitory function [169]. Loss of p53 thus provides two levels of growth advantage to tumour cells; it removes two mechanisms of eliminating the cell in response to genotoxic stress, and at the same time, enables cell survival under limiting nutrient conditions. Paradoxically, each of these exploits the same process, autophagy, utilizing its opposing functions.

The existence of p53 in short lived organisms that do not develop adult cancers, such as flies and worms, suggests that tumour suppression is not the only or, indeed, the original function of p53. Indeed, recent studies have shown that p53 and its family members, including p63 and p73, all play important roles in reproduction [170,171]. Emerging evidence has suggested that p53 is also an important but complex player in the regulation of aging and longevity in worms, flies, mice, and humans. The impact of p53 on aging and longevity in humans has been recently indicated by several epidemiological studies [172,173]. Moreover longevity is always coupled with the age of attaining reproductive maturity in animals. The later in life that reproductive maturity occurs, the greater the longevity of that animal. Animals will most often not reproduce in times of stress and starvation of nutrients and will shut down their reproductive processes. Indeed, p53 in adult worms and flies is predominantly localized in the germline where it is employed in the prevention of reproduction in response to stress signals such as DNA damage and starvation. Thus p53 has its origins, in an evolutionary sense, as a germline surveillance molecule under conditions of starvation or DNA damage [171]. It is only in vertebrates, where the body plan requires self-renewal of tissues (flies and worms are largely post-mitotic as adults, except for the germline), where the p53 protein is found in somatic tissues and takes on the function of a tumour suppressor.

p53 interacts with IGF-1, TOR and Sirt-1 pathways, the critical pathways that regulate aging and longevity [174,175] (Figure 2). There are two major connections between the proteins of these three pathways that form a rapid and a slower response to stress signals after activation of p53. First, the rapid signal transduction pathway responds to DNA damage by the activation of p53 and AMPK, which in turn activates TSC2 via phosphorylation [176,177]. This inactivates RHEB and then mTOR and shuts down translation while turning on autophagy. These events are p53 dependent in a cell, as well as TSC1–TSC2 dependent after DNA damage, as demonstrated by using cells that had no p53, TSC1, or TSC2 genes (from knockout mice). A different stress signal such as glucose starvation rapidly activates this pathway involving p53 and AMPK. AMPK can induce p53 by promoting phosphorylation on serine-15, a site known to be important for the activation of p53 [176]. There is a second wave of communication between p53 and the IGF-1–AKT and TOR pathways. Thus, Mak et al. [178] first demonstrated that PTEN was induced by the activation of p53. Cell lines or mouse tissues that transcriptionally activated the PTEN gene after DNA damage also induced TSC2 gene transcription. The p53-mediated induction of PTEN and TSC2 acts in the same way as the faster p53–AMPK pathway. Increasing PTEN levels shuts down AKT activity and relieves its inhibition on TSC2, resulting in the inactivation of TOR, loss of phosphorylation of S6 kinase, and activation of autophagy [176,179]. Similarly, the activation of AKT-1 and mTOR by the presence of nutrients and growth factors leads to the AKT-1-dependent activation of MDM2 by phosphorylation, which enhances its activity as a ubiquitin ligase and moves it into the nucleus so that it more effectively degrades and inactivates p53 [180].

Conclusion

Here, we have reviewed the role of caloric restriction in longevity and argued that p53 is the connection in the abilities of both the Sirt-1 pathway and the TOR pathway to impact on longevity of cells and organisms. Furthermore the integration of the p53 pathway with the IGF-1 and TOR pathways brings together a number of overlapping concepts that play a central role in life processes. Through the transcriptional regulation of different target genes (PTEN, AMPK, Sestrin 1/2, TSC2) p53 negatively regulates the insulin/IGF-1 and TOR signaling, creating an interpathway network that permits cells to inhibit cell growth and division to avoid the introduction of errors during these processes under stress conditions (Figure 3). In this way, p53 increases the fidelity of these processes over the lifetime of an organism. Since decreased TOR/insulin/IGF-1 signaling extends life span, p53 may regulate aging and longevity through its down-regulation of the signaling of these two critical pathways.

This novel, lifespan regulating function of p53 may be evolutionarily more ancient than its relatively recent role in apoptosis and tumour suppression, and is likely to provide many new insights into lifespan modulation.


Notes

The author of this manuscript has no conflict of interests to declare.

This work has been supported by the Medical Research Council, UK.


Abbreviations
CR caloric restriction
ROS reactive oxygen species
mTOR mammalian target of rapamycin
IGF-1 insulin-like growth factor-1
IGF-1R IGF-1 receptor

REFERENCES
Masoro EJ. Caloric restriction and aging: an updateExp. GerontolYear: 20093529930510832051
Sohal RS,Weindruch R. Oxidative stress, caloric restriction, and agingScienceYear: 199627359638658196
Gems D,Doonan R. Antioxidant defense and aging in C. elegansCell CycleYear: 200981681168719411855
Blagosklonny MV. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibitionCell CycleYear: 200652087210217012837
Pérez VI,Van Remmen H,Bokov A,Epstein CJ,Vijg J,Richardson A. The overexpression of major antioxidant enzymes does not extend the lifespan of miceAging CellYear: 20098737519077044
Chen Y,Azad MB,Gibson SB. Superoxide is the major reactive oxygen species regulating autophagyCell Death DifferYear: 2009161040105219407826
Doonan R,McElwee JJ,Matthijssens F,Walker GA,Houthoofd K,Back P,et al. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegansGenes DevYear: 2008223236324119056880
Mair W,Dillin A. Aging and survival: the genetics of life span extension by dietary restrictionAnnu Rev BiochemYear: 20087772775418373439
Bauer J,et al. Comparative transcriptional profiling identifies takeout as a gene that regulates life spanAgingYear: 2010229831020519778
McKeller MR,Herrera-Rodriguez S,Ma W,Ortiz-Quintero B,Rangel R,Candé C,Sims-Mourtada JC,Melnikova V,Kashi C,Phan LM,Chen Z,Huang P,Dunner K Jr.,Kroemer G,Singh KK,Martinez-Valdez H. Vital function of PRELI and essential requirement of its LEA motifCell Death DisYear: 20101e2121364629
Zhao C,Tan YC,Wong WC,Sem X,Zhang H,Han H,Ong SM,Wong KL,Yeap WH,Sze SK,Kourilsky P,Wong SC. The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(−) subsetCell Death DisYear: 20101e9521368871
Bose R,Moors M,Tofighi R,Cascante A,Hermanson O,Ceccatelli S. Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterationsCell Death DisYear: 20101e9221368868
Yan L,Mieulet V,Lamb RF. Nutrient regulation of mTORC1 and cell growthCell CycleYear: 20109132473247420543582
Ma B,Sen T,Asnaghi L,Valapala M,Yang F,Hose S,McLeod DS,Lu Y,Eberhart C,Zigler JS Jr,Sinha D. βA3/A1-Crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/AKT/mTOR and ERK survival pathways through the PKD/Bit1-signaling axisCell Death DisYear: 20112e21721993393
Soliman GA. The integral role of mTOR in lipid metabolismCell CycleYear: 20111086186221325894
Zha X,Sun Q,Zhang H. mTOR upregulation of glycolytic enzymes promotes tumor developmentCell CycleYear: 2011101015101621393998
Kim S,Snyder SH. Nutrient amino acids signal to mTOR via inositol polyphosphate multikinaseCell CycleYear: 20111017081021633199
Conn CS,Qian SB. mTOR signaling in protein homeostasis: Less is more?Cell CycleYear: 2011101940194721555915
Won Jun Oh,Jacinto E. mTOR complex 2 signaling and functionsCell CycleYear: 2011102305231621670596
Pani G. From growing to secreting: New roles for mTOR in aging cellsCell CycleYear: 2011102450245321720215
Anisimov VN,Zabezhinski MA,Popovich IG,Piskunova TS,Semenchenko AV,Tyndyk M,Yurova M,Rosenfeld S,Blagosklonny MV. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female miceCell CycleYear: 2011104230423622107964
Schneider-Jakob S,Corazza N,Badmann A,Sidler D,Stuber-Roos R,Keogh A,Frese S,Tschan M,Brunner T. Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and BidCell Death DisYear: 20101e8621368859
Reis CR,van der Sloot AM,Natoni A,Szegezdi E,Setroikromo R,Meijer M,Sjollema K,Stricher F,Cool RH,Samali A,Serrano L,Quax WJ. Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variantsCell Death DisYear: 20101e8321368856
Heidari N,Hicks MA,Harada H. GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagyCell Death DisYear: 20101e7621364679
Flourakis M,Lehen'kyi V,Beck B,Raphaël M,Vandenberghe M,Abeele FV,Roudbaraki M,Lepage G,Mauroy B,Romanin C,Shuba Y,Skryma R,Prevarskaya N. Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cellsCell Death DisYear: 20101e7521364678
Jiang CC,Lai F,Tay KH,Croft A,Rizos H,Becker TM,Yang F,Liu H,Thorne RF,Hersey P,Zhang XD. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimSCell Death DisYear: 20101e6921364673
Gonzalez-Mejia ME,Voss OH,Murnan EJ,Doseff AI. Apigenin-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27Cell Death DisYear: 20101e6421364669
Fricker M,O'Prey J,Tolkovsky AM,Ryan KM. Phosphorylation of Puma modulates its apoptotic function by regulating protein stabilityCell Death DisYear: 20101e5921364664
Placzek WJ,Wei J,Kitada S,Zhai D,Reed JC,Pellecchia M. A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapyCell Death DisYear: 20101e4021364647
Olsson M,Zhivotovsky B. Caspases and cancerCell Death DifferYear: 2011181441144921455218
Graber TE,Holcik M. Distinct roles for the cellular inhibitors of apoptosis proteins 1 and 2Cell Death DisYear: 20112e13521430708
Mühlethaler-Mottet A,Flahaut M,Balmas Bourloud K,Nardou K,Coulon A,Liberman J,Thome M,Gross N. Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosisCell Death DisYear: 2012e125
Cheung HH,St Jean M,Beug ST,Lejmi-Mrad R,LaCasse E,Baird SD,Stojdl D,Screaton RA,Korneluk RG. MG1 and NIK regulate apoptosis induced by Smac mimetic compoundsCell Death DisYear: 20112e14621490678
Yivgi-Ohana N,Eifer M,Addadi Y,Neeman M,Gross A. Utilizing mitochondrial events as biomarkers for imaging apoptosisCell Death DisYear: 20112e16621633389
Rauert H,Stühmer T,Bargou R,Wajant H,Siegmund D. TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanismsCell Death DisYear: 20112e19421850048
Teng X,Cheng W,Qi B,Yu T,Ramachandran K,Boersma MD,Hattier T,Lehmann P,Pineda FJ,Hardwick JM. Gene-dependent cell death in yeastCell Death DisYear: 20112e18821814286
Knight RA,Melino G. Cell death in disease: from 2010 onwardsCell Death DisYear: 20112e20221881604
Seervi M,Joseph J,Sobhan PK,Bhavya B,Santhoshkumar TR. Essential requirement of cytochrome c release for caspase activation by procaspase-activating compound defined by cellular modelsCell Death DisYear: 20112e20721900958
Gonzalez-Halphen D,Ghelli A,Iommarini L,Carelli V,Esposti MD. Mitochondrial complex I and cell death: a semi-automatic shotgun modelCell Death DisYear: 20112e22222030538
Kober AM,Legewie S,Pforr C,Fricker N,Eils R,Krammer PH,Lavrik IN. Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activationCell Death DisYear: 20112e21221975294
Vanlangenakker N,Bertrand MJM,Bogaert P,Vandenabeele P,Vanden Berghe T. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II membersCell Death DisYear: 20112e23022089168
Lee SH,Jung Y,Chung J,Oh A,Lee S,Choi D,Jang S,Jang K,Paik S,Ha N,Park B. Novel tumor suppressive function of Smad4 in serum starvation-induced cell death through PAK1-PUMA pathwayCell Death DisYear: 20112e23522130069
Wu Y,Tan H,Huang Q,Sun X,Zhu X,Shen H. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFα mediated by the PKC-MAPKs-AP-1 pathwayCell Death DifferYear: 201018263720539307
Wang X,Olberding K,White C,Li C. Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosisCell Death DifferYear: 201018384720539308
Lian J,Wu X,He F,Karnak D,Tang W,Meng Y,Xiang D,Ji M,Lawrence T,Xu L. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulumCell Death DifferYear: 201018607120577262
Choi H,Chang J,Jung Y. Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspaseCell Death DifferYear: 20101840541420829884
Niture S,Jaiswal A. INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosisCell Death DifferYear: 20101843945120865015
De Zio D,Bordi M,Tino E,Lanzuolo C,Ferraro E,Mora E,Ciccosanti F,Fimia GM,Orlando V,Cecconi F. The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damageCell Death DifferYear: 20101851652720966962
Lalier L,Cartron P,Olivier C,Logé C,Bougras G,Robert JM,Oliver Land,Vallette FM. Prostaglandins antagonistically control Bax activation during apoptosisCell Death DifferYear: 20101852853720966963
Schug ZT,Gonzalvez F,Houtkooper RH,Vaz FM,Gottlieb E. BID is cleaved by caspase-8 within a native complex on the mitochondrial membraneCell Death DifferYear: 20101853854821072056
Sirois I,Raymond M,Brassard N,Cailhier J,Fedjaev M,Hamelin K,London I,Bendayan M,Pshezhetsky A,Hébert M. Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communicationCell Death DifferYear: 20101854956220966960
Zhang L,Lopez H,George N,Liu X,Pang X,Luo X. Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathwaysCell Death DifferYear: 20101886487321113147
Ge R,Wang Z,Zeng Q,Xu X,Olumi AF. F-box protein 10, an NF-κB-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating c-Fos/c-FLIP pathwayCell Death DifferYear: 2011181184119521252908
Hui K,Kanungo A,Elia A,Henderson JT. Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell deathCell Death DifferYear: 2011181780179021597464
Badiola N,Penas C,Miñano-Molina A,Barneda-Zahonero B,Fadó R,Sánchez-Opazo G,Comella J,Sabriá J,Zhu C,Blomgren K,Casas C,Rodríguez-Alvarez J. Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12Cell Death DisYear: 20112e14921525936
Cordeiro MF,Guo L,Coxon KM,Duggan J,Nizari S,Normando EM,Sensi SL,Sillito AM,Fitzke FW,Salt TE,Moss SE. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivoCell Death DisYear: 20101e321364622
Engel T,Tanaka K,Jimenez-Mateos EM,Caballero-Caballero A,Prehn JH,Henshall DC. Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticusCell Death DisYear: 20101e7921368852
Di Guardo G,Marruchella G. Prions and neuronal deathCell Death DisYear: 20101e621364625
Bunk EC,König HG,Bernas T,Engel T,Henshall DC,Kirby BP,Prehn JH. BH3-only proteins BIM and PUMA in the regulation of survival and neuronal differentiation of newly generated cells in the adult mouse hippocampusCell Death DisYear: 20101e1521364616
Corasaniti MT,Melino G,Navarra M,et al. Death of cultured human neuroblastoma-cells induced by hiv-1 gp120 is prevented by nmda receptor antagonists and inhibitors of nitric-oxide and cyclooxygenaseNeurodegenarationYear: 19953315321
Bagetta G,Corasaniti MT,Melino G,et al. Lithium and tacrine increase the expression of nitric-oxide synthase messenger-RNA in the hippocampus of ratBiochem. and Biophys. Res. CommYear: 1997311321139
Agostini M,Tucci P,Chen H,et al. p73 regulates maintenance of neural stem cellBiochem. and Biophys. Res. CommYear: 2010403131720977890
Lim MP,Devi LA,Rozenfeld R. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosisCell Death DisYear: 20112e17021654828
Blume-Jensen P,Hunter T. Oncogenic kinase signallingNatureYear: 200141135536511357143
Romano S,D'Angelillo A,Staibano S,Ilardi G,Romano MF. FK506-binding protein 51 is a possible novel tumoral markerCell Death DisYear: 20101e5521364660
Knauer SK,Heinrich UR,Bier C,Habtemichael N,Docter D,Helling K,Mann WJ,Stauber RH. An otoprotective role for the apoptosis inhibitor protein survivinCell Death DisYear: 20101e5121364656
Giampietri C,Petrungaro S,Coluccia P,Antonangeli F,Giannakakis K,Faraggiana T,Filippini A,Cossu G,Ziparo E. c-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle agingCell Death DisYear: 20101e3821364645
Pasupuleti N,Matsuyama S,Voss O,Doseff AI,Song K,Danielpour D,Nagaraj RH. The anti-apoptotic function of human αA-crystallin is directly related to its chaperone activityCell Death DisYear: 20101e3121364639
Chu KM,Minogue S,Hsuan JJ,Waugh MG. Differential effects of the phosphatidylinositol 4-kinases, PI4KIIα and PI4KIIIβ, on Akt activation and apoptosisCell Death DisYear: 20101e10621218173
Mitchell G,Fillinger J,Sittadjody S,Avila J,Burd R,Limesand K. IGF1 activates cell cycle arrest following irradiation by reducing binding of ΔNp63 to the p21 promoterCell Death DisYear: 20101e5021480565
Sears D,Luong P,Yuan M,Nteliopoulos G,Man YK,Melo JV,Basu S. Functional phosphoproteomic analysis reveals cold-shock domain protein A to be a Bcr-Abl effector-regulating proliferation and transformation in chronic myeloid leukemiaCell Death DisYear: 20101e9321368869
Datta SR,Dudek H,Tao X,Masters S,Fu H,Gotoh Y,Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machineryCellYear: 1997912312419346240
Del Peso L,Gonzalez-Garcia M,Page C,Herrera R,Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase AktScienceYear: 19972786876899381178
Zhou BP,Liao Y,Xia W,Zou Y,Spohn B,Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylationNat. Cell BiolYear: 2001397398211715018
Inoki K,Li Y,Zhu T,Wu J,Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signallingNat. Cell BiolYear: 2002464865712172553
Potter CJ,Pedraza LG,Xu T. Akt regulates growth by directly phosphorylating Tsc2Nat. Cell BiolYear: 2002465866512172554
Liu H,Zhang Y,Yang N,Zhang Y,Liu X,Li C,Zhao Y,Wang Y,Zhang G,Yang P,Guo F,Sun Y,Jiang C. A functionalized single-walled carbon nanotube-induced autophagic cell death in human lung cells through Akt-TSC2-mTOR signalingCell Death DisYear: 20112e15921593791
Kang Y,Lu M,Guan K. The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosisCell Death DifferYear: 20101813314420616807
Gao X,Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growthGenes & DevYear: 2001151383139211390358
Inoki K,Li Y,Xu T,Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signalingGenes & DevYear: 2003171829183412869586
Zhang Y,Gao X,Saucedo LJ,Ru B,Edgar BA,Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNat. Cell BiolYear: 2003557858112771962
Perumalsamy LR,Nagala M,Banerjee P,Sarin A. A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cellsCell Death DifferYear: 2009687988919265851
Levine B,Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostorCell Death DifferYear: 2009161219079285
Huang Q,Wu YT,Tan HL,Ong CN,Shen HM. A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stressCell Death DifferYear: 20091626427718974775
Sarkar S,Ravikumar B,Floto RA,Rubinsztein DC. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related protein-pathiesCell Death DifferYear: 200916465618636076
Inoki K,Zhu T,Guan KL. TSC2 mediates cellular energy response to control cell growth and survivalCellYear: 200311557759014651849
Hay N,Sonenberg N. Upstream and downstream of mTORGenes & DevYear: 2004181926194515314020
Silver N,Proctor GB,Arno M,Carpenter GH. Activation of mTOR coincides with autophagy during ligation-induced atrophy in the rat submandibular glandCell Death DisYear: 20101e1420890458
Vellai T. Autophagy genes and ageingCell Death DifferYear: 2009169410219079287
Levine B,Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostorCell Death DifferYear: 2009161219079285
Eisenberg-Lerner A,Bialik S,Simon HU,Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between themCell Death DifferYear: 20091696697519325568
Scarlatti F,Granata R,Meijer AJ,Codogno AP. Does autophagy have a license to kill mammalian cells?Cell Death DifferYear: 200916122018600232
Noda T,Fujita N,Yoshimori T. The late stages of autophagy: how does the end begin?Cell Death DifferYear: 20091698499019424283
Fimia GM,Piacentini M. Toward the understanding of autophagy regulation and its interplay with cell death pathwaysCell Death DifferYear: 20091693393419528948
Ling L,Tan K,Lin H,Chiu G. The role of reactive oxygen species and autophagy in safingol-induced cell deathCell Death DisYear: 20112e12921390063
Donadelli M,Dando I,Zaniboni T,Costanzo C,Dalla Pozza E,Scupoli MT,Scarpa A,Zappavigna S,Marra M,Abbruzzese A,Bifulco M,Caraglia M,Palmieri M. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanismCell Death DisYear: 20112e15221525939
Russo R,Berliocchi L,Adornetto A,Varano GP,Cavaliere F,Nucci F,Rotiroti D,Morrone LA,Bagetta G,Corasaniti MT. Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivoCell Death DisYear: 20112e14421490676
Kuwahara Y,Oikawa T,Ochiai Y,Roudkenar MH,Fukumoto M,Shimura T,Ohtake Y,Ohkubo Y,Mori S,Uchiyama Y,Fukumoto M. Enhancement of autophagy is a potential modality for tumors refractory to radiotherapyCell Death DisYear: 20112e17721716292
Tomic T,Botton T,Cerezo M,Robert G,Luciano F,Puissant A,Gounon P,Allegra M,Bertolotto C,Bereder JM,Tartare-Deckert S,Bahadoran P,Auberger P,Ballotti R,Rocchi S. Metformin inhibits melanoma development through autophagy and apoptosis mechanismsCell Death DisYear: 20112e19921881601
Kang R,Zeh HJ,Lotze MT,Tang D. The Beclin 1 network regulates autophagy and apoptosisCell Death DifferYear: 20111857158021311563
Barth JMI,Szabad J,Hafen E,Köhler K. Autophagy in Drosophila ovaries is induced by starvation and is required for oogenesisCell Death DifferYear: 20101891592421151027
Vara D,Salazar M,Olea-Herrero N,Guzmán M,Velasco G,Díaz-Laviada I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagyCell Death DifferYear: 2011181099111121475304
Laussmann MA,Passante E,Düssmann H,Rauen JA,Würstle ML,Delgado ME,Devocelle M,Prehn JHM,Rehm M. Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8Cell Death DifferYear: 2011181584159721455219
Gomes LC,Di Benedetto G,Scorrano L. Essential amino acids and glutamine regulate induction of mitochondrial elongation during autophagyCell CycleYear: 2011102635263921811092
Boehrer S,Lainey E,Kroemer G. Coordinated epigenetic regulation of autophagy and apoptosisCell CycleYear: 2011102832321869599
Liang XH,Jackson S,Seaman M,Brown K,Kempkes B,Hibshoosh H,et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1NatureYear: 199940267267610604474
Nishida K,Kyoi S,Yamaguchi O,Sadoshima J,Otsu K. The role of autophagy in the heartCell Death DifferYear: 200916313819008922
Deng L,Feng J,Broaddus RR. The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stressCell Death DisYear: 2010e3221072319
Bennett HL,Fleming JT,O'Prey J,Ryan KM,Leung HY. Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cellsCell Death DisYear: 20101e7221364676
Marino ML,Fais S,Djavaheri-Mergny M,Villa A,Meschini S,Lozupone F,Venturi G,Della Mina P,Pattingre S,Rivoltini L,Codogno P,De Milito A. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cellsCell Death DisYear: 20101e8721368860
Heidari N,Hicks MA,Harada H. GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagyCell Death DisYear: 20101e7621364679
Li Q,Li H,Roughton K,Wang X,Kroemer G,Blomgren K,Zhu C. Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemiaCell Death DisYear: 20101e5621364661
McCoy F,Hurwitz J,McTavish N,Paul I,Barnes C,O'Hagan B,Odrzywol K,Murray J,Longley D,McKerr G,Fennell DA. Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAKCell Death DisYear: 20101e10821368880
Ruela-de-Sousa RR,Fuhler GM,Blom N,Ferreira CV,Aoyama H,Peppelenbosch MP. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapyCell Death DisYear: 20101e1921364620
Wirawan E,Vande Walle L,Kersse K,Cornelis S,Claerhout S,Vanoverberghe I,Roelandt R,De Rycke R,Verspurten J,Declercq W,Agostinis P,Vanden Berghe T,Lippens S,Vandenabeele P. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondriaCell Death DisYear: 20101e1821364619
Liang C. Negative regulation of autophagyCell Death DifferYear: 2010121807181520865012
Foster DA,Toschi A. Targeting mTOR with rapamycinCell CycleYear: 200981026102919270529
Sarkar1 S,Ravikumar B,Floto RA,Rubinsztein DC. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamineexpanded huntingtin and related proteinopathiesCell Death DifferYear: 200916465618636076
Blagosklonny MV. TOR-driven agingCell CycleYear: 200984055405919923900
Blagosklonny MV. Rapamycin and quasi-programmed agingCell CycleYear: 201091859186220436272
Blagosklonny MV. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposalCell CycleYear: 201094788479421150328
Blagosklonny MV. Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-programCell CycleYear: 201093151315620724817
Kim J,Guan KL. Regulation of the autophagy initiating kinase ULK1 by nutrients: Roles of mTORC1 and AMPKCell CycleYear: 20111013371338
Yu J,Henske EP. TORC1 activation and autophagy inhibition: Opposing forces in Rheb-driven tumorigenesisCell CycleYear: 20111038033800422142865
Cohen HY,Miller C,Bitterman KJ,Wall NR,Hekking B,Kessler B,et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylaseScienceYear: 200430539039215205477
Wood JG,Rogina B,Lavu S,Howitz K,Helfand SL,Tatar M,et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoansNatureYear: 200443068668915254550
Mostoslavsky R,Manel Esteller,Alejandro Vaquero. At the crossroad of lifespan, calorie restriction, chromatin and diseaseCell CycleYear: 201091907191220458180
Kaeberlein M,McVey M,Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanismsGenes DevelopYear: 1999132570258010521401
Tissenbaum HA,Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegansNatureYear: 200141022723011242085
Morselli E,Maiuri MC,Markaki M,Megalou E,Pasparaki A,Palikaras K,Criollo A,Galluzzi L,Malik SA,Vitale I,Michaud M,Madeo F,Tavernarakis N,Kroemer G. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagyCell Death DisYear: 20101e1021364612
Blagosklonny MV. Linking calorie restriction to longevity through sirtuins and autophagy: any role for TORCell Death DisYear: 20101e1221364614
Campagna M,Herranz D,Garcia MA,Marcos-Villar L,González-Santamaría J,Gallego P,Gutierrez S,Collado M,Serrano M,Esteban M,Rivas C. SIRT1 stabilizes PML promoting its sumoylationCell Death DifferYear: 201018727920577263
Stein S,Matter CM. Protective roles of SIRT1 in atherosclerosisCell CycleYear: 2011106404721293192
Antosh M,Whitaker R,Kroll A,Hosier S,Chang C,Bauer J,Cooper L,Neretti N,Helfand SL. Comparative transcriptional pathway bioinformatic analysis of dietary restriction, Sir2, p53 and resveratrol life span extension in DrosophilaCell CycleYear: 2011109041121325893
Milner J,Allison SJ. SIRT1, p53 and mitotic chromosomesCell CycleYear: 201110304921908974
Medvedik O,Lamming DW,Kim KD,Sinclair DA. MSN2 and MSN4 link calorie restriction and TOR to Sirtuin-mediated lifespan extension in Saccharomyces cerevisiaePLoS BiolYear: 20075e26117914901
Demidenko ZN,Blagosklonny MV. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescenceCell CycleYear: 200981901190419471118
Linzer DIH,Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cellsCellYear: 1979174352222475
Lane D,Crawford LV. T-antigen is bound to a host protein in SV40-transformed cellsNatureYear: 1979278261263218111
Deleo AB,et al. Detection of a transformed-related antigen in chemically induced sarcomas and other transformed cells of the mouseProc. Natl Acad. Sci. USAYear: 19797624202424221923
Mahmoudi S,Henriksson S,Farnebo L,Roberg K,Farnebo M. WRAP53 promotes cancer cell survival and is a potential target for cancer therapyCell Death DisYear: 20102e11421368886
Finlay CA,Hinds PW,Levine AJ. The p53 proto-oncogene can act as a suppressor of transformationCellYear: 198957108310932525423
Chen PL,Chen YL,Bookstein R,Lee WH. Genetic mechanisms of tumor suppression by the human p53 geneScienceYear: 1990250157615802274789
Mitchell GC,Fillinger JL,Sittadjody S,Avila JL,Burd R,Limesand KH. IGF1 activates cell cycle arrest following irradiation by reducing binding of ΔNp63 to the p21 promoterCell Death DisYear: 20101e5021480565
Engel T,Tanaka K,Jimenez-Mateos EM,Caballero-Caballero A,Prehn JH,Henshall DC. Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticusCell Death DisYear: 20101e7921368852
Fricker M,O'Prey J,Tolkovsky AM,Ryan KM. Phosphorylation of Puma modulates its apoptotic function by regulating protein stabilityCell Death DisYear: 20101e5921364664
Meley D,Spiller DG,White MR,McDowell H,Pizer B,Sée V. p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastomaCell Death DisYear: 20101e4121364648
Rello-Varona S,Kepp O,Vitale I,Michaud M,Senovilla L,Jemaà M,Joza N,Galluzzi L,Castedo M,Kroemer G. An automated fluorescence videomicroscopy assay for the detection of mitotic catastropheCell Death DisYear: 20101e2521364633
Gonzalez-Cano L,Herreros-Villanueva M,Fernandez-Alonso R,Ayuso-Sacido A,Meyer G,Garcia-Verdugo JM,Silva A,Marques MM,Marin MC. p73 deficiency results in impaired self renewal and premature neuronal differentiation of mouse neural progenitors independently of p53Cell Death DisYear: 20101e10921368881
Yuan M,Luong P,Hudson C,Gudmundsdottir K,Basu S. c-Abl phosphorylation of ΔNp63α is critical for cell viabilityCell Death DisYear: 20101e1621364617
Ramadan S,Terrinoni A,Catani MV,et al. p73 induces apoptosis by different mechanismsBiochem. Biophys. Res. CommYear: 200533171371715865927
Catani MV,Rossi A,Costanzo A,et al. Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damageBiochemical JournalYear: 2001356778511336638
Melino G. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53Cell Death DifferYear: 2011181487149921760596
Collavin L,Lunardi A,Del Sal G. p53-family proteins and their regulators: hubs and spokes in tumor suppressionCell Death DifferYear: 20101790117911
Yalcin-Ozuysal O,Fiche M,Guitierrez M,Wagner KU,Raffoul W,Brisken C. Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fatesCell Death DifferYear: 2010171600161220379195
Cheok CF,Kua N,Kaldis P,Lane DP. Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53Cell Death DifferYear: 2010171486150020203688
Marine JC. p53 stabilization: the importance of nuclear importCell Death DifferYear: 20101719119220062067
Lambertz I,Nittner D,Mestdagh P,Denecker G,Vandesompele J,Dyer MA,Marine JC. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivoCell Death DifferYear: 20101763364120019750
Christoffersen NR,Shalgi R,Frankel LB,Leucci E,Lees M,Klausen M,Pilpel Y,Nielsen FC,Oren M,Lund AH. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYCCell Death DifferYear: 20101723624519696787
Hermeking H. The miR-34 family in cancer and apoptosisCell Death DifferYear: 20101719319919461653
Davies L,Spiller D,White MRH,Grierson I,Paraoan L. PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cellsCell Death DisYear: 20112e13621451571
Koster R,Timmer-Bosscha H,Bischoff R,Gietema JA,de Jong S. Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathwayCell Death DisYear: 20112e14821509038
Sermeus A,Michiels C. Reciprocal influence of the p53 and the hypoxic pathwaysCell Death DisYear: 20112e16421614094
Vaseva AV,Yallowitz AR,Marchenko ND,Xu S,Moll UM. Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumorsCell Death DisYear: 20112e15621562588
Graupner V,Alexander E,Overkamp T,Rothfuss O,De Laurenzi V,Gillissen BF,Daniel PT,Schulze-Osthoff K,Essmann F. Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter levelCell Death DifferYear: 2011181130113921233848
Gao W,Shen Z,Shang L,Wang X. Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell deathCell Death DifferYear: 2011181598160721475306
Spinnler C,Hedström E,Li H,de Lange J,Nikulenkov F,Teunisse AF,Verlaan-de Vries M,Grinkevich V,Jochemsen AG,Selivanova G. Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmXCell Death DifferYear: 2011181736174521546907
Marcel V,Dichtel-Danjoy ML,Sagne C,Hafsi H,Ma D,Ortiz-Cuaran S,Olivier M,Hall J,Mollereau B,Hainaut P,Bourdon JC. Biological functions of p53 isoforms through evolution: lessons from animal and cellular modelsCell Death DifferYear: 2011181815182421941372
Maiuri MC,Tasdemir E,Criollo A,Morselli E,Vicencio JM,Carnuccio R,Kroemer G. Control of autophagy by oncogenes and tumor suppressor genesCell Death DifferYear: 200916879318806760
Hu W,Feng Z,Teresky AK,Levine AJ. p53 regulates maternal reproduction through LIFNatureYear: 200745072172418046411
Levine AJ,Tomasini R,McKeon FD,Mak TW,Melino G. The p53 family: guardians of maternal reproductionNat Rev Mol Cell BiolYear: 20111225926521427767
Van Heemst D,Mooijaart SP,Beekman M,et al. Variation in the human TP53 gene affects old age survival and cancer mortalityExp GerontolYear: 20054011515732191
Orsted DD,Bojesen SE,Tybjaerg-Hansen A,Nordestgaard BG. Tumor suppressor p53 Arg-72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general populationJ Exp MedYear: 20072041295130117535973
Bauer JH,Helfand SL. Sir2 and longevity. The p53 connectionCell CycleYear: 200981818182219471123
Jung-Hynes B,Ahmad N. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cellsCell CycleYear: 200981478148319377286
Feng Z,Zhang H,Levine AJ,Jin S. The coordinate regulation of the p53 and mTOR pathways in cellsProc. Natl. Acad. SciYear: 20051028204820915928081
Saha AK,Xu X,Balon TW,Brandon A,Kraegen EW,Ruderman NB. Insulin resistance due to nutrient excess: Is it a consequence of AMPK downregulation?Cell CycleYear: 2011103447345122067655
Stambolic V,MacPherson D,Sas D,Lin Y,Snow B,Jang Y,Benchimol S,Mak TW. Regulation of PTEN transcription by p53Mol. CellYear: 2001831732511545734
Matthew EM,Hart Lori S,Aristotelis Astrinidis,Arunasalam Navaraj,Dolloff Nathan G,Dicker David T,Henske Elizabeth P,El-Deiry Wafik S. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditionsCell CycleYear: 200984168417520054236
Gottlieb TM,Leal JF,Seger R,Taya Y,Oren M. Cross-talk between Akt, p53 and Mdm2: Possible implications for the regulation of apoptosisOncogeneYear: 2002211299130311850850

Figures

[Figure ID: F1]
Figure 1 

The regulation of longevity by caloric restriction.



[Figure ID: F2]
Figure 2 

Linking caloric restriction (CR), sirtuins, and mTOR to the p53 pathway. CR and resveratrol activate autophagy through sirtuins, thus extending lifespan. The intracellular mTOR pathway via inputs of PI-3K, AMPK and other sensors integrates nutrient availability and drives cell growth and aging. Rapamycin and resveratrol inhibit the Sirtuin/mTOR network. CR and p53 may also inhibit mTOR activity through upregulation of known negative regulators PTEN, TSC2 and AMPK. The products of two p53 target genes, Sestrin 1 and 2 activate AMPK, which phosphorylates TSC2 and stimulates its GAP activity enabling mTOR inhibition. Glucose starvation inhibits mTOR by promoting TSC1/2 activation.



[Figure ID: F3]
Figure 3 

The new and complex role of p53 in regulating aging and longevity through the transcriptional regulation of different target genes.



Article Categories:
  • Review

Keywords: p53, senescence, aging, caloric restriction, apoptosis, cell death, cell cycle.

Previous Document:  Combined hyoid bone flap in laryngeal reconstruction after extensive partial laryngectomy for laryng...
Next Document:  Complex impacts of an invasive omnivore and native consumers on stream communities in California and...